Article Details
Retrieved on: 2021-11-15 17:30:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Guselkumab is a monoclonal antibody that targets the p19 subunit of interleukin (IL)-23, and was shown in two pivotal phase III trials to be ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here